Molecular expression and functional activity of efflux and influx transporters in hypoxia induced retinal pigment epithelial cells

International Journal of Pharmaceutics

Volumn 454, Issue 1, 2013, Pages 444-452

  Vadlapatla, Ramya Krishna ^a   Vadlapudi, Aswani Dutt ^a   Ponnaluri, V K Chaithanya ^a   Pal, Dhananjay ^a   Mukherji, Mridul ^a   Mitra, Ashim K ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Efflux and influx transporters; Hypoxia; Molecular expression and functional activity; Retinal pigment epithelial cells

Indexed keywords

ABACAVIR; AMINO ACID TRANSPORTER; ARGININE; BIOTIN; BREAST CANCER RESISTANT PROTEIN; CARRIER PROTEIN; DIGOXIN; EFFLUX TRANSPORTER; FOLATE RECEPTOR 1; FOLIC ACID; INFLUX TRANSPORTER; LOPINAVIR; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL DEATH; CELL HYPOXIA; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMIDITY; IMMUNOBLOTTING; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84884127806     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.06.044     Document Type: Article

References (51)

1. Anand, B.S., Dey, S., Mitra, A.K., 2002. Current prodrug strategies via membrane transporters/receptors. Expert Opin. Biol. Ther. 2, 607-620.
2. Arden, G.B., Sivaprasad, S., 2011. Hypoxia and oxidative stress in the causation of diabetic retinopathy. Curr. Diab. Rev. 7, 291-304.
3. Arjamaa, O., Nikinmaa, M., 2006. Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors. Exp. Eye Res. 83, 473-483. (Pubitemid 43902768)
4. Boidot, R., Vegran, F., Meulle, A., Le Breton, A., Dessy, C., Sonveaux, P., Lizard-Nacol, S., Feron, O., 2012. Regulation of monocarboxylate transporter MCT1 expression by p53 mediates inward and outward lactate fluxes in tumors. Cancer Res. 72, 939-948.
5. Caprara, C., Grimm, C., 2012. From oxygen to erythropoietin: relevance of hypoxia for retinal development, health and disease. Prog. Retin. Eye Res. 31, 89-119.
6. Cheng, G.M., To, K.K., 2012. Adverse cell culture conditions mimicking the tumor microenvironment upregulate ABCG2 to mediate multidrug resistance and a more malignant phenotype. ISRN Oncol. 2012, 746025.
7. Comerford, K.M., Wallace, T.J., Karhausen, J., Louis, N.A., Montalto, M.C., Colgan, S.P., 2002. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 62, 3387-3394. (Pubitemid 34651384)
8. Constable, P.A., Lawrenson, J.G., Dolman, D.E., Arden, G.B., Abbott, N.J., 2006. P-glycoprotein expression in human retinal pigment epithelium cell lines. Exp. Eye Res. 83, 24-30. (Pubitemid 43783239)
9. Davis, A.A., Bernstein, P.S., Bok, D., Turner, J., Nachtigal, M., Hunt, R.C., 1995. A human retinal pigment epithelial cell line that retains epithelial characteristics after prolonged culture. Invest. Ophthalmol. Vis. Sci. 36, 955-964.
10. Epstein, A.C., Gleadle, J.M., McNeill, L.A., Hewitson, K.S., O'Rourke, J., Mole, D.R., Mukherji, M., Metzen, E., Wilson, M.I., Dhanda, A., Tian, Y.M., Masson, N., Hamilton, D.L., Jaakkola, P., Barstead, R., Hodgkin, J., Maxwell, P.H., Pugh, C.W., Schofield, C.J., Ratcliffe, P.J., 2001. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54. (Pubitemid 32972036)
11. Ganapathy, M.E., Ganapathy, V., 2005. Amino acid transporter ATB0,+ as a delivery system for drugs and prodrugs. Curr. Drug Targets Immune Endocr. Metabol. Disord. 5, 357-364. (Pubitemid 41722378)
12. Geisen, P., McColm, J.R., King, B.M., Hartnett, M.E., 2006. Characterization of barrier properties and inducible VEGF expression of several types of retinal pigment epithelium in medium-term culture. Curr. Eye Res. 31, 739-748. (Pubitemid 44373546)
13. Giaccia, A.J., Simon, M.C., Johnson, R., 2004. The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease. Genes Dev. 18, 2183-2194. (Pubitemid 39209567)
14. Gibson, J.S., Cossins, A.R., Ellory, J.C., 2000. Oxygen-sensitive membrane transporters in vertebrate red cells. J. Exp. Biol. 203, 1395-1407. (Pubitemid 30351510)
15. Hayreh, S.S., 2008. Role of retinal hypoxia in diabetic macular edema: a new concept. Graefes Arch. Clin. Exp. Ophthalmol. 246, 353-361. (Pubitemid 351247984)
16. Hirota, K., Semenza, G.L., 2006. Regulation of angiogenesis by hypoxia-inducible factor 1. Crit. Rev. Oncol. Hematol. 59, 15-26. (Pubitemid 43903276)
17. 2-regulated prolyl hydroxylation. Science 292, 468-472.
18. Janoria, K.G., Boddu, S.H., Wang, Z., Paturi, D.K., Samanta, S., Pal, D., Mitra, A.K., 2009. Vitreal pharmacokinetics of biotinylated ganciclovir: role of sodium-dependent multivitamin transporter expressed on retina. J. Ocul. Pharmacol. Ther. 25, 39-49.
19. Jewell, U.R., Kvietikova, I., Scheid, A., Bauer, C., Wenger, R.H., Gassmann, M., 2001. Induction of HIF-1alpha in response to hypoxia is instantaneous. FASEB J. 15, 1312-1314.
20. Jwala, J., Vadlapatla, R.K., Vadlapudi, A.D., Boddu, S.H., Pal, D., Mitra, A.K., 2012. Differential expression of folate receptor-alpha, sodium-dependent multivitamin transporter, and amino acid transporter (B (0, +)) in human retinoblastoma (Y-79) and retinal pigment epithelial (ARPE-19) cell lines. J. Ocul. Pharmacol. Ther. 28, 237-244.
21. Katragadda, S., Talluri, R.S., Mitra, A.K., 2006. Modulation of P-glycoprotein-mediated efflux by prodrug derivatization: an approach involving peptide transporter-mediated influx across rabbit cornea. J. Ocul. Pharmacol. Ther. 22, 110-120. (Pubitemid 43742947)
22. Ke, Q., Costa, M., 2006. Hypoxia-inducible factor-1 (HIF-1). Mol. Pharmacol. 70, 1469-1480.
23. Kennedy, B.G., Mangini, N.J., 2002. P-glycoprotein expression in human retinal pigment epithelium. Mol. Vis. 8, 422-430. (Pubitemid 36153633)
24. Krishnamurthy, P., Ross, D.D., Nakanishi, T., Bailey-Dell, K., Zhou, S., Mercer, K.E., Sarkadi, B., Sorrentino, B.P., Schuetz, J.D., 2004. The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J. Biol. Chem. 279, 24218-24225. (Pubitemid 38725283)
25. Krishnamurthy, P., Schuetz, J.D., 2005. The ABC transporter Abcg2/Bcrp: role in hypoxia mediated survival. Biometals 18, 349-358. (Pubitemid 41298019)
26. Li, Y., Ye, D., 2010. Cancer therapy by targeting hypoxia-inducible factor-1. Curr. Cancer Drug Targets 10, 782-796.
27. Lopez-Barneo, J., Pardal, R., Ortega-Saenz, P., 2001. Cellular mechanism of oxygen sensing. Annu. Rev. Physiol. 63, 259-287.
28. Majumdar, S., Duvvuri, S., Mitra, A.K., 2004. Membrane transporter/receptor-targeted prodrug design: strategies for human and veterinary drug development. Adv. Drug Deliv. Rev. 56, 1437-1452. (Pubitemid 38748825)
29. Mannermaa, E., Vellonen, K.S., Ryhanen, T., Kokkonen, K., Ranta, V.P., Kaarniranta, K., Urtti, A., 2009. Efflux protein expression in human retinal pigment epithelium cell lines. Pharm. Res. 26, 1785-1791.
30. Mannermaa, E., Vellonen, K.S., Urtti, A., 2006. Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. Adv. Drug Deliv. Rev. 58, 1136-1163.
31. Nakanishi, T., Ross, D.D., 2012. Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression. Chin. J. Cancer 31, 73-99.
32. Natarajan, K., Xie, Y., Baer, M.R., Ross, D.D., 2012. Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance. Biochem. Pharmacol. 83, 1084-1103.
33. Penn, J.S., Li, S., Naash, M.I., 2000. Ambient hypoxia reverses retinal vascular attenuation in a transgenic mouse model of autosomal dominant retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 41, 4007-4013.
34. Pierce, E.A., Avery, R.L., Foley, E.D., Aiello, L.P., Smith, L.E., 1995. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. U.S.A. 92, 905-909.
35. Ponnaluri, V.K., Vadlapatla, R.K., Vavilala, D.T., Pal, D., Mitra, A.K., Mukherji, M., 2011. Hypoxia induced expression of histone lysine demethylases: implications in oxygen-dependent retinal neovascular diseases. Biochem. Biophys. Res. Commun. 415, 373-377.
36. Semenza, G.L., 2000. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol. 88, 1474-1480. (Pubitemid 30217451)
37. Semenza, G.L., 2012. Hypoxia-inducible factors in physiology and medicine. Cell 148, 399-408.
38. Slomiany, M.G., Rosenzweig, S.A., 2004. IGF-1-induced VEGF and IGFBP-3 secretion correlates with increased HIF-1 alpha expression and activity in retinal pigment epithelial cell line D407. Invest. Ophthalmol. Vis. Sci. 45, 2838-2847. (Pubitemid 38998884)
39. Smith, L.E., 2003. Pathogenesis of retinopathy of prematurity. Semin. Neonatol. 8, 469-473. (Pubitemid 37474717)
40. Smith, S.B., Kekuda, R., Gu, X., Chancy, C., Conway, S.J., Ganapathy, V., 1999. Expression of folate receptor alpha in the mammalian retinol pigmented epithelium and retina. Invest. Ophthalmol. Vis. Sci. 40, 840-848. (Pubitemid 29153249)
41. Soh, H., Wasa, M., Fukuzawa, M., 2007. Hypoxia upregulates amino acid transport in a human neuroblastoma cell line. J. Pediatr. Surg. 42, 608-612. (Pubitemid 46589519)
42. Staud, F., Pavek, P., 2005. Breast cancer resistance protein (BCRP/ABCG2). Int. J. Biochem. Cell Biol. 37, 720-725. (Pubitemid 40202994)
43. Stefansson, E., 2001. The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmol. Scand. 79, 435-440. (Pubitemid 32962830)
44. Tan, S.C., Carr, C.A., Yeoh, K.K., Schofield, C.J., Davies, K.E., Clarke, K., 2012. Identification of valid housekeeping genes for quantitative RT-PCR analysis of cardiosphere-derived cells preconditioned under hypoxia or with prolyl-4-hydroxylase inhibitors. Mol. Biol. Rep. 39, 4857-4867.
45. Tezel, G., Wax, M.B., 2004. Hypoxia-inducible factor 1alpha in the glaucomatous retina and optic nerve head. Arch. Ophthalmol. 122, 1348-1356. (Pubitemid 39180857)
46. Vadlapudi, A.D., Vadlapatla, R.K., Mitra, A.K., 2012a. Sodium dependent multivitamin transporter (SMVT): a potential target for drug delivery. Curr. Drug Targets 13, 994-1003.
47. Vadlapudi, A.D., Vadlapatla, R.K., Pal, D., Mitra, A.K., 2012b. Functional and molecular aspects of biotin uptake via SMVT in human corneal epithelial (HCEC) and retinal pigment epithelial (D407) cells. AAPS J. 14, 832-842.
48. Vavilala, D.T., Ponnaluri, V.K., Vadlapatla, R.K., Pal, D., Mitra, A.K., Mukherji, M., 2012. Honokiol inhibits HIF pathway and hypoxia-induced expression of histone lysine demethylases. Biochem. Biophys. Res. Commun. 422, 369-374.
49. 2 tension. Proc. Natl. Acad. Sci. U.S.A. 92, 5510-5514.
50. Wang, G.L., Semenza, G.L., 1995. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270, 1230-1237.
51. Wu, W.C., Kao, Y.H., Hu, P.S., Chen, J.H., 2007. Geldanamycin, a HSP90 inhibitor, attenuates the hypoxia-induced vascular endothelial growth factor expression in retinal pigment epithelium cells in vitro. Exp. Eye Res. 85, 721-731.